185 related articles for article (PubMed ID: 36319558)
1. Cytoreductive surgery in patients with oligometastatic prostate cancer. Systematic review of the scientific literature.
Ruiz Aragón J; Jiménez Varo E; Ruiz Aragón AI; Revelo Cadena I; Agüera Sánchez Á; Jiménez Romero ME
Actas Urol Esp (Engl Ed); 2023; 47(6):332-340. PubMed ID: 36319558
[TBL] [Abstract][Full Text] [Related]
2. [Our experience with cytoreductive radical prostatectomy in patients with oligometastatic prostate cancer].
Berczi C; Dócs J; Flaskó T
Orv Hetil; 2021 Mar; 162(13):483-487. PubMed ID: 33774598
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review.
Becker JA; Berg KD; Røder MA; Brasso K; Iversen P
Scand J Urol; 2018 Feb; 52(1):1-7. PubMed ID: 28818014
[TBL] [Abstract][Full Text] [Related]
4. The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer.
Ranasinghe W; Chapin BF; Kim IY; Sooriakumaran P; Lawrentschuk N
BJU Int; 2020 Jun; 125(6):792-800. PubMed ID: 32176456
[TBL] [Abstract][Full Text] [Related]
5. Current Controversy and Developments Regarding the Cytoreductive Prostatectomy for Oligometastatic Prostate Cancer.
Tian Y; Mao Y; Tang Z; Hu M
Technol Cancer Res Treat; 2023; 22():15330338231216011. PubMed ID: 38105493
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in oligometastatic prostate cancer: Is there a role for radical prostatectomy?
Marenco J; Sooriakumaran P
Arch Esp Urol; 2019 Mar; 72(2):174-181. PubMed ID: 30855019
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?
Slaoui A; Albisinni S; Aoun F; Assenmacher G; Al Hajj Obeid W; Diamand R; Regragui S; Touzani A; Bakar A; Mesfioui A; Karmouni T; Ameur A; Elkhader K; Koutani A; Ibnattya A; Roumeguere T; Peltier A
World J Urol; 2019 Nov; 37(11):2343-2353. PubMed ID: 30706122
[TBL] [Abstract][Full Text] [Related]
8. Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trial.
Mandel PC; Huland H; Tiebel A; Haese A; Salomon G; Budäus L; Tilki D; Chun F; Heinzer H; Graefen M; Pantel K; Riethdorf S; Steuber T
Eur Urol Focus; 2021 Jan; 7(1):55-62. PubMed ID: 31178293
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?
Mathieu R; Korn SM; Bensalah K; Kramer G; Shariat SF
World J Urol; 2017 Apr; 35(4):567-577. PubMed ID: 27502935
[TBL] [Abstract][Full Text] [Related]
10. Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease.
Heidenreich A; Pfister D
Curr Opin Urol; 2020 Jan; 30(1):90-97. PubMed ID: 31724996
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive Radical Prostatectomy for Metastatic Hormone-sensitive Prostate Cancer-Evidence from Recent Prospective Reports.
Rajwa P; Zattoni F; Maggi M; Marra G; Kroyer P; Shariat SF; Briganti A; Montorsi F; Heidegger I; Gandaglia G;
Eur Urol Focus; 2023 Jul; 9(4):637-641. PubMed ID: 36697321
[TBL] [Abstract][Full Text] [Related]
12. [Surgical treatment of local disease in metastatic prostate cancer.].
Gaya JM; Huguet J; Breda A; Palou J
Arch Esp Urol; 2018 Mar; 71(3):288-297. PubMed ID: 29633950
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive prostatectomy: what is the evidence? A systematic review.
Albisinni S; Aoun F; Diamand R; Al-Hajj Obeid W; Porpiglia F; Roumeguère T; De Nunzio C
Minerva Urol Nefrol; 2019 Feb; 71(1):1-8. PubMed ID: 30547907
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive radical prostatectomy versus systemic therapy and radiation therapy in metastatic prostate cancer: A systematic review and meta-analysis.
Shemshaki H; Al-Mamari SA; Geelani IA; Kumar S
Urologia; 2022 Feb; 89(1):16-30. PubMed ID: 34355602
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
Heidenreich A; Pfister D; Porres D
J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
[TBL] [Abstract][Full Text] [Related]
16. Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study).
Buelens S; Poelaert F; Claeys T; De Bleser E; Dhondt B; Verla W; Ost P; Rappe B; De Troyer B; Verbaeys C; Kimpe B; Billiet I; Plancke H; Fransis K; Willemen P; Ameye F; Decaestecker K; Lumen N
BJU Int; 2022 Jun; 129(6):699-707. PubMed ID: 34289231
[TBL] [Abstract][Full Text] [Related]
17. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis.
Cheng B; Ye S; Bai P
World J Surg Oncol; 2021 May; 19(1):160. PubMed ID: 34051809
[TBL] [Abstract][Full Text] [Related]
19. Role of radical prostatectomy in metastatic prostate cancer: A review.
Metcalfe MJ; Smaldone MC; Lin DW; Aparicio AM; Chapin BF
Urol Oncol; 2017 Apr; 35(4):125-134. PubMed ID: 28190749
[TBL] [Abstract][Full Text] [Related]
20. Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging.
Robesti D; Gallina A; Montorsi F; Briganti A; Fossati N
Curr Opin Urol; 2024 Jul; 34(4):294-299. PubMed ID: 38587018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
